320 related articles for article (PubMed ID: 30564952)
1. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
Al-Mamgani A; Navran A; Walraven I; Schreuder WH; Tesselaar MET; Klop WMC
Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):575-583. PubMed ID: 30564952
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.
Janoray G; Pointreau Y; Alfonsi M; Sire C; Geoffrois L; de Raucourt D; Bardet E; Calais MH; Garaud P; Calais G
Eur J Cancer; 2020 Jul; 133():86-93. PubMed ID: 32454417
[TBL] [Abstract][Full Text] [Related]
3. Organ Function Preservation Failure after (Chemo)Radiotherapy in Head and Neck Cancer: A Retrospective Cohort Analysis.
Heukelom J; Navran A; Gouw ZAR; Tesselaar ME; Zuur CL; van Werkhoven E; Sonke JJ; Rasch CRN; Al-Mamgani A
Otolaryngol Head Neck Surg; 2019 Aug; 161(2):288-296. PubMed ID: 31060436
[TBL] [Abstract][Full Text] [Related]
4. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
5. Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.
Bonner J; Giralt J; Harari P; Spencer S; Schulten J; Hossain A; Chang SC; Chin S; Baselga J
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):842-9. PubMed ID: 27389475
[TBL] [Abstract][Full Text] [Related]
6. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
[TBL] [Abstract][Full Text] [Related]
7. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
Lefebvre JL; Ang KK;
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
[TBL] [Abstract][Full Text] [Related]
8. Persistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancer.
Tennant PA; Cash E; Bumpous JM; Potts KL
Head Neck; 2014 Nov; 36(11):1628-33. PubMed ID: 24115178
[TBL] [Abstract][Full Text] [Related]
9. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
[TBL] [Abstract][Full Text] [Related]
10. Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.
Huh G; Ahn SH; Suk JG; Lee MH; Kim WS; Kwon SK; Ock CY; Keam B; Heo DS; Kim JH; Wu HG
Jpn J Clin Oncol; 2020 Feb; 50(2):185-192. PubMed ID: 31711185
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U
Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221
[TBL] [Abstract][Full Text] [Related]
12. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
[No Abstract] [Full Text] [Related]
13. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
14. Effect of daily fraction size on laryngoesophageal dysfunction after chemoradiation for squamous cell carcinomas of the larynx and hypopharynx.
Chen AM; Hsu S; Meshman J; Chin R; Beron P; Abemayor E; St John M
Head Neck; 2017 Jul; 39(7):1322-1326. PubMed ID: 28301066
[TBL] [Abstract][Full Text] [Related]
15. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
[No Abstract] [Full Text] [Related]
16. Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer.
Petersen JF; Arends CR; van der Noort V; Al-Mamgani A; de Boer JP; Stuiver MM; van den Brekel MWM
Oral Oncol; 2019 Aug; 95():143-149. PubMed ID: 31345382
[TBL] [Abstract][Full Text] [Related]
17. Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review.
Putten L; Bree R; Doornaert PA; Buter J; Eerenstein SE; Rietveld DH; Kuik DJ; Leemans CR
Acta Otorhinolaryngol Ital; 2015 Jun; 35(3):162-72. PubMed ID: 26246660
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.
Paximadis P; Yoo G; Lin HS; Jacobs J; Sukari A; Dyson G; Christensen M; Kim H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1515-21. PubMed ID: 21658855
[TBL] [Abstract][Full Text] [Related]
19. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
[TBL] [Abstract][Full Text] [Related]
20. Neck Management with Total Laryngectomy and Adjuvant Radiotherapy in Locally Advanced Larynx Cancer.
Kennedy WR; Amdur RJ; Boyce BJ; Dziegielewski P; Morris CG; Mendenhall WM
Oncol Res Treat; 2017; 40(9):503-506. PubMed ID: 28848123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]